Lucintel's latest market report analyzed that injection pen provides attractive opportunities in home-care settings and hospitals & diagnostic clinics. The injection pen market is expected to reach $52.9 billion by 2028 with a CAGR of 7%. In this market, disposable injection pens is the largest segment by product type, whereas home-care setting is largest by end use.

Download Brochure of this report by clicking on https://www.lucintel.com/injection-pen-market.aspx

Based on product type, the injection pen market is segmented into isposable injection pens and reusable injection pens. The disposable injection pens segment accounted for the largest share of the market in 2023 and is expected to register the highest CAGR during the forecast period, due to as it helps in avoiding the risk of cross-contamination and needle stick injuries associated with reusable injection pens.

Browse in-depth TOC on “Injection Pen Market”

100 – Figures/Tables

150 – Pages

The Injection Pen Market is marked by the presence of several big and small players. Some of the prominent players offering injection pen include Novo Nordisk, Becton, Ypsomed Holding, Sanofi, Eli Lilly and Company, Merck KGaA, AstraZeneca, Roche, Owen Mumford, and Sulzer.

Request Sample Report:

https://www.lucintel.com/injection-pen-market.aspx

This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or click on this link helpdesk@lucintel.com.

About Lucintel

Lucintel, the premier global management consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, growth consulting, M&A, and due diligence services to executives and key decision-makers in a variety of industries. For further information, visit www.lucintel.com.